Oramed Pharmaceuticals Inc.ORMPNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-14.87M
Near historical average
Average (9y)
$-13.67M
Historical baseline
Range
High:$7.32M
Low:$-36.98M
CAGR
+8.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-14.87M | -303.2% |
| 2023 | $7.32M | +119.8% |
| 2022 | $-36.98M | -47.7% |
| 2021 | $-25.04M | -121.3% |
| 2020 | $-11.31M | +20.2% |
| 2019 | $-14.17M | -5.1% |
| 2018 | $-13.49M | -25.4% |
| 2017 | $-10.76M | -7.7% |
| 2016 | $-9.99M | -35.4% |
| 2015 | $-7.38M | - |